What Researchers Did
Researchers investigated changes in serum phospholipase A2 concentration and platelet aggregation during a 10-day course of hyperbaric oxygen therapy in 42 patients with stable ischemic heart disease.
What They Found
The provided abstract did not detail the specific findings regarding changes in serum phospholipase A2 concentration or platelet aggregation activity in response to hyperbaric oxygen therapy. Therefore, numerical results from the study could not be extracted.
What This Means for Canadian Patients
If hyperbaric oxygen therapy is shown to effectively modulate platelet activity and PLA2 levels, it could offer a novel therapeutic approach for Canadian patients with stable ischemic heart disease. This could potentially lead to improved management strategies for those with platelet haemostasis disorders.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
The provided abstract did not explicitly detail the study's limitations, though potential concerns might include the relatively small sample size and the absence of a placebo control group.